Quest Diagnostics IncorporatedStock Price and Value Analysis

Should you buy Quest Diagnostics Incorporated stock? (NYSE:DGX). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company is very stable.
  • This company has an average dividend yield.
  • This company has stable growth.
  • This stock looks overpriced.
  • This company is not making money.

DGX Free Cash Flow Trend

Hmm, we can't give any reliable projection for Quest Diagnostics Incorporated's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for DGX
Free Cash Flow trendline for Quest Diagnostics Incorporated

Inside the DGX Numbers

DGX Price
(Quest Diagnostics Incorporated stock price per share)
$97.09
[?] PE Ratio versus Sector 2% lower than other Healthcare stocks
[?] PE Ratio versus Industry 89% lower than other Medical Laboratories & Research stocks
[?] Cash Yield 6.43%
[?] Free Cash Flow Jitter 15%
[?] Dividend Yield 2%

Is Quest Diagnostics Incorporated Stock on Sale?

Based on our analysis, we believe that you should not buy Quest Diagnostics Incorporated right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy DGX Stock?

Does Quest Diagnostics Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.